The Potential Role of Coagulation Factor Xa in the Pathophysiology of COVID-19: A Role for Anticoagulants as Multimodal Therapeutic Agents

The Potential Role of Coagulation Factor Xa in the Pathophysiology of COVID-19: A Role for Anticoagulants as Multimodal Therapeutic Agents

SARS-CoV-2 infection (COVID-19) results in local and systemic activation of inflammation and coagulation. In this review article, we will discuss the potential role of coagulation factor Xa (FXa) in the pathophysiology of COVID-19. FXa, a serine protease, has been shown to play a role in the cleavag...

Full description

Bibliographic Details
Main Authors:	Galit H. Frydman, Michael B. Streiff, Jean M. Connors, Gregory Piazza
Format:	Article
Language:	English
Published:	Georg Thieme Verlag KG 2020-10-01
Series:	TH Open
Subjects:	sars-cov-2 coronavirus covid-19 coagulation factor x factor xa anticoagulants
Online Access:	http://www.thieme-connect.de/DOI/DOI?10.1055/s-0040-1718415

Similar Items

The Potential Role of Coagulation Factor Xa in the Pathophysiology of COVID-19: A Role for Anticoagulants as Multimodal Therapeutic Agents
by: Frydman, Galit H., et al.
Published: (2021)

Thrombin and factor Xa link the coagulation system with liver fibrosis
by: Ameet Dhar, et al.
Published: (2018-05-01)

Viscoelastometry for detecting oral anticoagulants
by: Philipp Groene, et al.
Published: (2021-03-01)

Modulation of T Cell Function by Coagulation Factor Xa
by: Chatterjee, Kaustav
Published: (2011)

Modulation of T Cell Function by Coagulation Factor Xa
by: Chatterjee, Kaustav
Published: (2011)

ERA OF NEW ANTICOAGULANTS IN THE TREATMENT OF NON-VALVULAR ATRIAL FIBRILLATION: PROSPECTS AND CHALLENGES
by: Z. M. Safiullina, et al.
Published: (2015-09-01)

Anti-factor Xa levels in obese patients receiving enoxaparin for treatment and prophylaxis indications
by: Tahaineh L, et al.
Published: (2018-05-01)

Synthesis, Docking, and In Vitro Anticoagulant Activity Assay of Hybrid Derivatives of Pyrrolo[3,2,1-<i>ij</i>]Quinolin-2(1<i>H</i>)-one as New Inhibitors of Factor Xa and Factor XIa
by: Nadezhda Novichikhina, et al.
Published: (2020-04-01)

Factor Xa Inhibition, A New Strategy for Prevention of Adverse Cardiac Remodeling in Early Stages?∗
by: Biykem Bozkurt, MD, PhD
Published: (2020-01-01)

The In Vitro Effects of Pentamidine Isethionate on Coagulation and Fibrinolysis
by: Rami A. Al-Horani, et al.
Published: (2019-06-01)

Bleeding issues in women prescribed anticoagulation
by: V. Speed, et al.
Published: (2021-12-01)

Anti–factor Xa activity assays of direct‐acting oral anticoagulants during clinical care: An observational study
by: Smrithi Sukumar, et al.
Published: (2021-05-01)

The Relative Efficacy of Chemically Diverse Small-Molecule Enzyme-Inhibitors Against Anticoagulant Activities of African Spitting Cobra (Naja Species) Venoms
by: Abhinandan Chowdhury, et al.
Published: (2021-10-01)

Host-Parasite Relationships in Porcine Ascariosis: Anticoagulant Potential of the Third Larval Stage of <i>Ascaris suum</i> as a Possible Survival Mechanism
by: Alicia Diosdado, et al.
Published: (2021-03-01)

Anticoagulant Activities of Indobufen, an Antiplatelet Drug
by: Jia Liu, et al.
Published: (2018-06-01)

Safety of 4-factor prothrombin complex concentrate (4F-PCC) for emergent reversal of factor Xa inhibitors
by: Jing Tao, et al.
Published: (2018-06-01)

New Oral Anticoagulants: General Features and Review of Pivotal Clinical Trials
by: Sung-Won Jang
Published: (2016-12-01)

Bleeding complications in patients with gastrointestinal cancer and atrial fibrillation treated with oral anticoagulants
by: Anne Gulbech Ording, et al.
Published: (2021-07-01)

Coagulation Parameters: An Efficient Measure for Predicting the Prognosis and Clinical Management of Patients with COVID-19
by: Manuel Quintana-Díaz, et al.
Published: (2020-10-01)

Coronavirus disease (COVID-19) and disseminated intravascular coagulation syndrome
by: A. D. Makatsariya, et al.
Published: (2020-07-01)

Prophylactic anti-coagulation after severe burn injury in critical care settings
by: Megan Blake, et al.
Published: (2019-05-01)

Inhibitory Effect of Triterpenoids from Panax ginseng on Coagulation Factor X
by: Lingxin Xiong, et al.
Published: (2017-04-01)

Are Reduced Levels of Coagulation Proteins Upon Admission Linked to COVID-19 Severity and Mortality?
by: Francisco C. Ceballos, et al.
Published: (2021-09-01)

Venous thrombosis recurrence risk according to warfarin versus direct oral anticoagulants for the secondary prevention of venous thrombosis
by: Neil A. Zakai, et al.
Published: (2021-08-01)

Dental extractions on direct oral anticoagulants vs. warfarin: The DENTST study
by: Yvonne Brennan, et al.
Published: (2020-02-01)

Inhibition of thrombin generation 12 hours after intake of direct oral anticoagulants
by: Michael Metze, et al.
Published: (2020-05-01)

Self‐reported therapy adherence and predictors for nonadherence in patients who switched from vitamin K antagonists to direct oral anticoagulants
by: Myrthe M. A. Toorop, et al.
Published: (2020-05-01)

Lupus Antibody Mimicking Reduced Plasmatic Coagulation in a Patient With Atrial Fibrillation and Ischemic Stroke
by: Aydin Huseynov, et al.
Published: (2020-08-01)

Anticoagulation in the Elderly
by: Helia Robert-Ebadi, et al.
Published: (2010-12-01)

Etiology of Ischemic Strokes of Patients with Atrial Fibrillation and Therapy with Anticoagulants
by: Jan C. Purrucker, et al.
Published: (2020-09-01)

NEW ORAL ANTICOAGULANT DRUGS IN ATRIAL FIBRILLATION AND ACUTE CORONARY SYNDROME
by: Aleksandra Novaković, et al.
Published: (2013-09-01)

COVID-19: Potential role of prophylactic anticoagulation in preventing thrombotic events and mortality. Narrative review
by: Maximiliano Gabriel Castro, et al.
Published: (2021-02-01)

Clinical implication of monitoring rivaroxaban and apixaban by using anti-factor Xa assay in patients with non-valvular atrial fibrillation
by: Kozue Ikeda, MD, et al.
Published: (2016-02-01)

Reversing factor Xa inhibitors – clinical utility of andexanet alfa
by: Kaatz S, et al.
Published: (2017-09-01)

The role of autolysis loop in determining the specificity of coagulation proteases
by: L. Yang, et al.
Published: (2007-08-01)

Direct Oral Anticoagulants in Dental Patients Including the Frail Elderly Population
by: Hui Yin Lim, et al.
Published: (2016-03-01)

Atrial fibrillation in patients with end‐stage renal disease on hemodialysis: Magnitude of the problem and new approach to oral anticoagulation
by: Oliver Königsbrügge, et al.
Published: (2019-10-01)

Management of major bleeding in patients treated with direct oral anticoagulants: from experience to standardized protocols
by: Sara Mascia, et al.
Published: (2020-06-01)

BLOOD COAGULATION FACTOR V: ISOLATION OF BOVINE PLASMA FACTOR V AND ITS ACTIVATION BY FACTOR XA, THROMBIN, AND A PROTEASE FROM RUSSELL'S VIPER VENOM
by: Smith, Catherine Margaret, 1947-
Published: (1976)

Development and implementation of a coagulation factor testing method utilizing autoverification in a high-volume clinical reference laboratory environment
by: Paul W Riley, et al.
Published: (2017-01-01)